Bright Minds Biosciences (DRUG) Interest & Investment Income (2024 - 2026)

Bright Minds Biosciences (DRUG) has 3 years of Interest & Investment Income data on file, last reported at $2.0 million in Q1 2026.

• Quarterly Interest & Investment Income rose 452.54% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 777.43% YoY) and the FY2025 annual result came in at $1.1 million, up 4898.39% from the prior year.
• Interest & Investment Income improved to $2.0 million in Q1 2026, from $586766.6 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $2.0 million in Q1 2026 to a low of $3091.0 in Q4 2024.
• A 3-year average of $456275.3 and a median of $349348.9 in 2025 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2025 — Interest & Investment Income surged 18882.84% — and 2026, when it jumped 452.54%.
• Tracing DRUG's Interest & Investment Income over 3 years: stood at $3091.0 in 2024, then surged by 18882.84% to $586766.6 in 2025, then jumped by 234.29% to $2.0 million in 2026.
• The last three Interest & Investment Income figures came in at $2.0 million (Q1 2026), $586766.6 (Q4 2025), and $384780.8 (Q3 2025), per Business Quant data.